Stockholm, November 10, 2010 — NASDAQ OMX (NASDAQ: NDAQ) announces that trading in Isconova (ISCO) shares will commence today, November 10, on First North at NASDAQ OMX Stockholm. Isconova belongs to the Health Care sector and is the seventh company to be admitted to trading on First North in 2010. Jenny Rosberg, Senior Vice President at NASDAQ OMX, said, “We are happy to welcome Isconova to First North and look forward to supporting them in growing their visibility towards investors on a local, European and global level. We congratulate Isconova to be the first Pharmaceuticals investment opportunity within the Health Care sector on First North.” Lena Söderström, CEO of Isconova, commented, “We are very pleased to welcome 800 new shareholders to Isconova. Now, we look forward to pursue our strategy with increased focus on the big and fast growing market for human vaccines, and to further strengthen our position within veterinary vaccines. Also, listing at First North will increase our visibility, not only towards our investors and the general public, but also towards existing and future partners.” - # - About First North First North is regulated as a multilateral trading facility, operated by the different exchanges within NASDAQ OMX Nordic. It does not have the legal status as an EU-regulated market. Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market. About NASDAQ OMX The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with more than 3,600 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit http://www.nasdaqomx.com. Please follow NASDAQ OMX on Facebook (http://www.facebook.com/nasdaqomx) and Twitter (http://www.twitter.com/nasdaqomx). Cautionary Note Regarding Forward-Looking Statements The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about NASDAQ OMX's products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements. NASDAQ OMX Media contacts: Anna Rasin +46 (8) 405 66 12 firstname.lastname@example.org
Nasdaq Press Center
Read the latest press releases, request a press kit, and get in touch with our press team.